Glenn Mattes, TFF Pharmaceuticals CEO
Texas biotech expands R&D and manufacturing capabilities following Catalent partnership
Only months after Texas-based TFF Pharmaceuticals netted a partnership with Catalent, the company is expanding its R&D and manufacturing operations in the capital of the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.